ArticleSurgical endoscopy2026
Predicting need for step-up approach and recurrence in endoscopic management of anastomotic strictures after esophagectomy: results from a 10-year multicenter retrospective study.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimsAnastomotic stricture (AS) is a common late complication after esophagectomy. Evidence guiding endoscopic escalation ("step-up") and the risk of post-treatment recurrence remains limited. We assessed clinical, surgical, and procedural determinants of (i) need for step-up therapy and (ii) recurrence after initial endoscopic success.
methodsWe conducted a multicenter retrospective study at two tertiary centers in Milan (2014-2024). Adults with naïve post-esophagectomy AS underwent standardized endoscopic management (bougie or pneumatic dilatation with predefined step-up options: incision therapy, stenting, steroid injection). Outcomes included technical (TS) and clinical success (CS), safety, rates of step-up and recurrence, and uni/multivariable predictors of change of strategy and recurrence.
resultsAmong 1729 esophagectomies, 61 patients (3.5%) developed benign AS. Initial therapy was bougie in 54.1% and pneumatic in 45.9%. TS was achieved in 100% and CS in 93.4%. Safety was favorable (1/61, 1.6%). Overall, 39.3% required a change of strategy, typically early: the first switch occurred at a median of 35 days, and in 62.5% within 30 days, most often for failure to achieve a ≥ 2-mm lumen gain (66.7%). On multivariable analysis, higher BMI (OR 0.81 per 1 kg/m
conclusionsEndoscopic treatment of post-esophagectomy AS is highly effective and safe, yet step-up intervention is required in nearly 40% and recurrence occurs in one quarter of patients. Nutritional status and baseline dysphagia help identify patients at higher risk of escalation, while stapled anastomoses appear to reduce recurrence. These findings support a risk-adapted, personalized endoscopic strategy and warrant prospective validation.
Indexed as
Identifiers
42141186What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.